Effect of vitamin D in the treatment of endometriosis
Phase 3
- Conditions
- Endometriosis.Endometriosis
- Registration Number
- IRCT20120718010324N78
- Lead Sponsor
- Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- 66
Inclusion Criteria
Women who have endometriosis and it has been confirmed by laparoscopy.
Women with symptomatic endometriosis.
Women who are married and sexually active.
Vitamin D serum level should be less than 30 ng/dl.
Exclusion Criteria
Patients with diabetes, thyroid disorders, high blood pressure, hyperprolactinemia and Cushing's syndrome
Daily and regular consumption of supplements containing vitamin D during the last three months
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Mean score of painful symptoms of endometriosis. Timepoint: Before intervention and 8 weeks after the start of treatment. Method of measurement: Menstrual painful symptoms questionnaire (ENDOPAIN-4D).
- Secondary Outcome Measures
Name Time Method Quality of lifemean score. Timepoint: Before intervention and 8 weeks after the start of treatment. Method of measurement: Endometriosis Health Profile-30.;Average severity of dysmenorrhea. Timepoint: Before intervention and 8 weeks after the start of treatment. Method of measurement: Visual Analog Scale.;The frequency of Gelofen consumption. Timepoint: During the treatment. Method of measurement: Checklist.;Adverse events. Timepoint: During the treatment. Method of measurement: Checklist.